MoneyWorks4Me

Sanofi India informs about board meeting

23 Oct 2017 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on Tuesday, 31st October 2017 to consider the unaudited financial results for the quarter ended 30th September 2017 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..